Log on / register
BioMed Central home | Journals A-Z | Feedback | Support
Open AccessResearch

DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk

Dominique Bernard-Gallon email, Remy Bosviel email, Laetitia Delort email, Luc Fontana email, Alain Chamoux email, Nadege Rabiau email, Fabrice Kwiatkowski email, Nassera Chalabi email, Samir Satih email and Yves-Jean Bignon email

Molecular Cancer 2008, 7:36doi:10.1186/1476-4598-7-36

Published: 2 May 2008

Abstract (provisional)

Breast and ovarian cancers increased in the last decades. Except rare cases with a genetic predisposition and high penetrance, these pathologies are viewed as a polygenic disease. In this concept, association studies look for genetic variations such as polymorphisms in low penetrance genes, i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from deleterious endogenous and exogenous damages have been shown to have significantly reduced. In particular, enzymes of the nucleotide excision repair pathway are suspected to be implicated in cancer. In this study, 2 functional polymorphisms in a DNA repair gene ERCC2 were analyzed. The population included 911 breast cancer cases, 51 ovarian cancer cases and 1000 controls. The genotyping of 2 SNP (Single Nucleotide Polymorphism) was carried out on the population with the MGB (Minor Groove Binder) probe technique which consists of the use of the allelic discrimination with the Taqman(R) method. This study enabled us to show an increase in risk of breast cancer with no oral contraceptive users and with women exhiting a waist-to-hip ratio (WHR) > 0.85 for Asn homozygous for ERCC2 312.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.


Published by
© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions